Trygg Pharma AS – a company that will be jointly owned by Aker BioMarine ASA and an affiliate of Lindsay Goldberg LLC through a newly established joint venture company (cf. the separate notice of today) – has entered into an agreement to acquire 100% of the shares in Epax Holding AS (together with its subsidiaries “Epax”), a wholly owned subsidiary of Austevoll Seafood ASA. Epax is the world’s premier high concentrate omega-3 supplement manufacturer. Epax employs a total of 74 people.
In July 2013, FMC Corporation acquired Epax Nutra Holding III AS (Norway) and Epax UK Holding III AS (United Kingdom) (together, Epax)
Japan’s Marine Product Imports Exceed Domestic Production Japan
The following is an excerpt from an article published by nippon.com:
Japan’s fishing industry is not the force that it once was, and in 2022 the country imported marine products worth ¥2 tr...
Fish face vast decline if emissions are not reduced Worldwide
The following is an excerpt from an article published by Dialogue Earth:
Failing to keep warming to below 3C could mean a 30% decline in catchable fish in many countries, huge study suggests
Gl...
Korean Market Situation for Shrimp and Cuttlefish South Korea
As of June 2024, the volume of frozen whiteleg shrimp imported into the country recorded 235 tons, a 72% decrease compared to the same period last year, and this figure is a significant decrease from ...